巨星醫療控股(02393.HK)擬5.75億元出售上海安百達投資、上海建儲醫療、上海超聯商貿、上海顥樂實業及上海定佩實業各94.2%股權
格隆匯12月30日丨巨星醫療控股(02393.HK)發佈公吿,2022年12月30日,賣方巨星醫療與買方李斌先生訂立股權轉讓協議,據此,賣方有條件同意出售而買方有條件同意收購目標公司(上海安百達投資、上海建儲醫療、上海超聯商貿、上海顥樂實業及上海定佩實業)各自的94.2%股本權益,代價為人民幣5.75億元。於完成後,公司將不再持有目標公司任何股本權益。
目標公司主要在上海銷售及經銷體外診斷產品、醫療設備及其他相關耗材。目標公司截至2021年12月31日止年度的總收益逾90%來自銷售及經銷體外診斷產品。在目標公司所銷售及經銷的體外診斷產品中,最具代表性者即為瑞士其中一個着名醫藥診斷品牌羅氏。另一方面,餘下集團將繼續根據其現有經銷權在上海以外地方經銷體外診斷產品,包括北京、廣州、深圳、福建、廣東、廣西、海南、湖南、江蘇、河北、安徽及內蒙古。目標公司與餘下集團的體外診斷產品經銷權彼此獨立,故銷售及經銷體外診斷產品的業務運作亦相互獨立。
出售事項的所得款項淨額將減少餘下集團的債務及降低資產負債比率,加強餘下集團的財務狀況。出售事項的所得款項淨額將用於償付餘下集團的未償還負債,減債,提高其流動性及整體財務狀況,對保持地方及國際競爭力及為股東締造長期增長而言至關重要。
董事會認為,監於(i)COVID-19對集團自2020年起的業務表現整體帶來負面影響及不確定因素(尤其是於上海市);(ii)買方作為創辦人於目標公司收購事項中的利益;及(iii)公司的財務狀況,出售事項乃集團將於目標公司的投資變現,並償還公司未償還負債的良機。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.